Fabry disease previously diagnosed as Henoch-Schonlein purpura
Ji Hyeong Kim, Dong Hoon Han, Moo Yong Park, Soo Jeong Choi, Jin Kuk Kim, Seung Duk Hwang, So Young Jin
Korean J Intern Med. 2015;30(6):925-927. Published online 2015 Oct 30 DOI: https://doi.org/10.3904/kjim.2015.30.6.925
Citations to this article as recorded by 
A questionnaire survey on the diagnosis and treatment of Fabry nephropathy in clinical practice
Soo Jeong Choi, Su Hyun Kim, Min Sung Lee, Samel Park, Eunjung Cho, Seung Seok Han, Eun Sil Koh, Byung Ha Chung, Kyung Hwan Jeong, EunHui Bae, Eun Young Lee, Young Joo Kwon
Kidney Research and Clinical Practice.2023; 42(5): 628. CrossRef
The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: A systematic literature review by a European panel of experts
Dominique P. Germain, Perry M. Elliott, Bruno Falissard, Victor V. Fomin, Max J. Hilz, Ana Jovanovic, Ilkka Kantola, Aleš Linhart, Renzo Mignani, Mehdi Namdar, Albina Nowak, João-Paulo Oliveira, Maurizio Pieroni, Miguel Viana-Baptista, Christoph Wanner, M
Molecular Genetics and Metabolism Reports.2019; 19: 100454. CrossRef
Fabry disease and immunoglobulin A nephropathy presenting with Alport syndrome-like findings
Hang Ren, Lin Li, Jiyun Yu, Shan Wu, Shanshan Zhou, Yang Zheng, Weixia Sun
Medicine.2019; 98(28): e16256. CrossRef
Dermatologic Aspects of Fabry Disease
Paula C. Luna, Paula Boggio, Margarita Larralde
Journal of Inborn Errors of Metabolism and Screening.2016; 4: 232640981666135. CrossRef